ABT-122: Clinical Trials

5 trials of ABT-122, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

4 completed, 1 terminated. 4 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	4	Completed 3, Terminated 1
Phase 1	1	Completed 1

Follow ABT-122: new trials by email Literature Review of ABT-122 trials Research Report on ABT-122

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 ABT-122 - Psoriatic Arthritis	Phase 2	Terminated	AbbVie	168	2015-10-01	2016-06-17
A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX) adalimumab, ABT-122 - Psoriatic Arthritis	Phase 2	Completed	AbbVie	240	2015-04-28	2017-08-04
Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study ABT-122 - Rheumatoid Arthritis	Phase 2	Completed	AbbVie	158	2015-04-01	2017-07-24
A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate adalimumab, ABT-122 - Rheumatoid Arthritis	Phase 2	Completed	AbbVie	222	2014-07-01	2016-11-11
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis ABT-122, Placebo - Rheumatoid Arthritis	Phase 1	Completed	AbbVie	19	2013-07-01	2017-11-20

Conditions studied

Sponsors

Countries

Top investigators

Results publications

NIH funding